JP2022116083A5
(cg-RX-API-DMAC7.html )
2023-01-20
JP2010047616A5
(cg-RX-API-DMAC7.html )
2010-10-14
AU2004208615B2
(en )
2007-05-03
Medicine for prevention of and treatment for arteriosclerosis and hypertension
RU2022100434A
(ru )
2022-03-11
Фармацевтические композиции, содержащие epa и сердечно-сосудистое средство, и способы их применения
HRP20241674T1
(hr )
2025-02-14
6'-[[(1s,3s)-3-[[5-(difluormetoksi)-2-pirimidinil]amino]ciklopentil]amino][1(2h),3'-bipiridin]-2-on kao inhibitor pcsk9 i postupci njegove upotrebe
MX2009003920A
(es )
2009-08-31
Estatina y acidos grasos omega 3 para reducir los niveles de apo b.
NZ552389A
(en )
2009-05-31
Statin pharmaceutical compositions and related methods of treatment
PL362477A1
(en )
2004-11-02
Hmg-coa reductase inhibitors and their use as medicaments for the treatment of cholesterol related diseases
FI3448426T3
(fi )
2025-07-18
Menetelmiä familiaalista hyperkolesterolemiaa sairastavien potilaiden hoitoon
JP2004537553A5
(cg-RX-API-DMAC7.html )
2006-01-05
JP2008509132A5
(cg-RX-API-DMAC7.html )
2008-09-04
PL377344A1
(pl )
2006-01-23
Lekarstwo do profilaktyki i leczenia miażdżycy tętnic i nadciśnienia
JP2016518338A5
(cg-RX-API-DMAC7.html )
2017-04-06
RU2017106896A
(ru )
2018-09-13
Антиметаногенные композиции и их применение
IL292829A
(en )
2022-07-01
Fixed dose combinations containing etc1002 and one or more statins to treat or reduce cardiovascular risk
WO2005046662A3
(en )
2005-06-23
Hdl-boosting combination therapy complexes
JP2006512361A5
(cg-RX-API-DMAC7.html )
2007-02-08
AR081032A1
(es )
2012-05-30
Formulacion farmaceutica en forma de comprimidos de dos capas que comprenden inhibidor de hmg-coa reductasa e irbesartan
RU2018133690A
(ru )
2020-03-26
Лечение пациентов с гомозиготной семейной гиперхолестеринемией, получающих липидоснижающую терапию
WO2000048626A3
(en )
2000-12-07
Aerosol compositions of hmg-coa reductase inhibitors for inhibiting inflammation associated with pulmonary disease
NZ603207A
(en )
2013-12-20
Combination of hmg-coa reductase inhibitors with phosphodiesterase 4 inhibitors for the treatment of inflammatory pulmonary diseases
IL178475A0
(en )
2007-02-11
Sustained release formulation for oral administration of hmg-coa reductase inhibitor and method for the preparation thereof
JP2007530528A5
(cg-RX-API-DMAC7.html )
2008-05-08
JP2008513379A5
(cg-RX-API-DMAC7.html )
2008-09-18
JP2006176498A5
(cg-RX-API-DMAC7.html )
2009-01-29